Updated:
MedTech Venture Partners
MedTech Venture Partners maintains offices in London, San Francisco, and Campbell, California, giving it coverage across European and North American...
MedTech Venture Partners
MedTech Venture Partners maintains offices in London, San Francisco, and Campbell, California, giving it coverage across European and North American healthcare innovation hubs. The firm targets medical technology companies developing surgical robotics, diagnostic imaging, and remote monitoring systems, typically investing at Series A through C rounds. Its known portfolio includes investments in AI-driven pathology and minimally invasive surgical tools, though specific company names are not publicly detailed (per public record). The firm's geographic reach spans the UK, Western Europe, and the US West Coast, with deal flow sourced from academic medical centers and corporate R&D units. Team size and total assets under management are not disclosed, and the firm does not publicly list any philanthropic or operating-company vehicles. No recent operational events have been publicly reported. MedTech Venture Partners differentiates itself by maintaining a pure medtech focus, avoiding broader healthcare bets in biotech or health services. Its bi-continental structure allows it to cross-leverage regulatory expertise from Europe and the US, particularly for device approvals and reimbursement strategy. The firm's governance and succession structure are not publicly documented.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Additional offices
San Francisco, CA, United States · Campbell, CA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at MedTech Venture Partners?
The firm does not publicly disclose its investment team or principals. Its operations span London and two California offices, but named decision-makers are not listed on any public source as of mid-2026.
How does MedTech Venture Partners source proprietary deal flow?
The firm's deal flow reportedly comes from direct relationships with hospital systems, academic research spinouts, and corporate R&D departments in Europe and the US. Its bi-continental presence likely gives it access to both NHS-affiliated innovations and Stanford/UCSF-area engineering startups.
Is MedTech Venture Partners structured as a single family office or a venture firm?
Based on its name and public descriptions, MedTech Venture Partners is an asset manager structured as a venture capital firm focused exclusively on medical technology. It does not present itself as a family office.
What investment stages does MedTech Venture Partners typically target?
The firm invests in early- to growth-stage medtech companies, typically Series A through C rounds. Its focus on surgical robotics, diagnostics, and connected devices suggests a preference for capital-intensive hardware-software hybrids.
Which sectors does MedTech Venture Partners explicitly avoid?
The firm appears to avoid biotech, pharmaceuticals, and health services, maintaining a pure medtech focus on devices, diagnostics, and digital health platforms. This narrow scope is its stated differentiator.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: